Moreover, molecular analysis studies have proven shared amino acids between DRB1*15:01, DRB1*03:01, and DRB1*04:03 alleles, conferring MS susceptibility by playing an important role in autoantigen presentation to T lymphocytes [3,25]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.